Saving changes...

Done

Error

Understanding CKD through the drug chart

Understanding CKD through the drug chart

Understanding CKD through the drug chart

Dr. John Agar
Dr. John Agar
on behalf of Medical Education Institute

$10.00 $ 10.00 $ 10.00

$10.00 $ 10.00 $ 10.00

$ 10.00 10.00 10.00
10.00 $ 10.00 10.00 10.00
Normal Price: $10.00 $10.00

Review:

Launch date: 27 Jan 2021
Expiry Date: 31 Oct 2022

Last updated: 07 Jul 2021

Reference: 196718

TIming: null

Maximum Attendees:

Places Left: 0

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

Ms Becky DeLaCruz CNNe, CHN (3 Feb 2021)
Great basic info for those working with CKD patients.
Nancy Gitaka (3 Feb 2021)
The course is very informative. Looking forward to future presentations.

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

Dialysis patients have many medications to help keep them healthy and balance the effects of dialysis. In this course, the learner will explore the various medications required to keep the patient in balance and address renal disease management. We will examine the drug chart and look at the purpose of the myriad of medication areas involved in dialysis disease management, as well as the management of comorbid conditions.

Objectives

1. Review the most common medications areas for dialysis patients.
Erythropoietin, iron, replacement dialysable vitamins, phosphate binders, Vitamin D, anti-hypertensives, anti-anginals, lipid-lowering agents, proton-pump inhibitors, primary disease management medications, management of acidosis, and other incidental medications.
2. Identify pros and cons of “old” phosphate binders vs. “new” phosphate binders
Phosphorus retention is a major problem for dialysis patients. Accumulation of phosphorus leads to renal osteodystrophy and atherosclerosis. "Old" binders like calcium and aluminum-based binders, are cheap, available, and easy to take. "New" binders are better, but more expensive and have more side-effects.
3. Describe the rationale behind use of ACEi and ARB drugs
Use of these drugs can reduce internal glomerular pressure, preventing sclerosis and helping protect against further glomerular loss, maintaining residual kidney function. However, the fall in glomerular pressure will reduce the GFR for each remaining working nephron. If there are too few glomeruli left, GFR may be effectively wiped out.
4. Create awareness of prescription load on dialysis patients
Patients take some meds several times daily. Some should be taken before meals, some with food, some after meals. Package sizes/prescription sizes vary, resulting in several trips to the pharmacy. World healthcare systems vary. In the United States, many patients cannot afford their medications.
Dr. John Agar

Author Information Play Video Bio

Dr. John Agar
on behalf of Medical Education Institute

Medical Education Institute, Inc. associate Dr. John Agar has over 50 years of experience, over 30 of those years as a Senior Physician of Nephrology at Geelong Hospital in Australia. He is an internationally-recognized award-winning nephrologist with over 200 peer-reviewed journal articles and abstracts.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • California Board of Registered Nursing (CBRN)
  • 1.50 Hours

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (2)

Go Back
Ms Becky DeLaCruz CNNe, CHN (3 Feb 2021)
Great basic info for those working with CKD patients.
Nancy Gitaka (3 Feb 2021)
The course is very informative. Looking forward to future presentations.

Loading...


Saving changes...

Done

Error